Inventor
CHRISTOPHER T. JONES
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
H04LTransmission of digital information, e.g. telegraphic communication4%
PatentTitleYear
12,522,596Compounds as GLP-1R agonists202612,485,118Combinations of GLP-1R and THRb agonists and methods of use thereof202512,486,261Compounds as GLP-1R agonists202512,410,163Compounds as GLP-IR agonists202512,378,236Compounds as GLP-1R agonists202512,378,238Compounds as GLP-1R agonists202512,378,237Compounds as GLP-1R agonists202512,378,239Compounds as GLP-1R agonists202512,024,507Compounds as GLP-1R agonists202411,431,764Combinable conference rooms2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to CHARTER COMMUNICATIONS OPERATING LLC (1)· patent assignee history
2022–2026Based in US· patent location history
2024–2026Patents assigned to TERNS PHARMACEUTICALS INC (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TERNS PHARMACEUTICALS INC | 9 | 2024–2026 |
| CHARTER COMMUNICATIONS OPERATING LLC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |